Atrial Fibrillation and Acute Myocardial Infarction – An Inflammation-Mediated Association

1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/ CIRCULATIONAHA.113.005119.10.1161/CIRCULATIONAHA.113.005119415130224345399Open DOISearch in Google Scholar

2. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142-1147. doi: 10.1016/j.amjcard.2013.05.063.10.1016/j.amjcard.2013.05.06323831166Open DOISearch in Google Scholar

3. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807-1824. doi: 10.1016/j.ijcard.2012.12.093.10.1016/j.ijcard.2012.12.09323380698Open DOISearch in Google Scholar

4. Oldgren J, Healey JS, Ezekowitz M, et al. RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014;129:1568-1576. doi: 10.1161/CIRCULATIONAHA.113.005451.10.1161/CIRCULATIONAHA.113.00545124463370Open DOISearch in Google Scholar

5. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017;00:1-66. doi:10.1093/eurheartj/ehx393.10.1093/eurheartj/ehx39328886621Open DOISearch in Google Scholar

6. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000;140:878-885.10.1067/mhj.2000.11110811099991Search in Google Scholar

7. Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction, results of the ARREST study. Europace. 2017;8:344. doi: 10.1093/europace/euw344.10.1093/europace/euw34428069838Open DOISearch in Google Scholar

8. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;39:1038-1045. doi: 10.1093/eurheartj/ehn579.10.1093/eurheartj/ehn57919109347Search in Google Scholar

9. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969-974.10.1161/01.CIR.101.9.969Search in Google Scholar

10. Kea B, Alligood T, Manning V, Raitt M. A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome. Current emergency and hospital medicine reports. 2016;4:107-118. doi: 10.1007/s40138-016-0105-2.10.1007/s40138-016-0105-2523242128090403Search in Google Scholar

11. McManus DD, Huang W, Domakonda KV, et al. Trends in Atrial Fibrillation in Patients Hospitalized with an Acute Coronary Syndrome. The American Journal of Medicine. 2012;125:1076-1084. doi: 10.1016/j.amjmed.2012.05.024.10.1016/j.amjmed.2012.05.024352451523098864Open DOISearch in Google Scholar

12. Angeli F, Reboldi G, Garofoli M, et al. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep. 2012;14:601-610. doi: 10.1007/s11886-012-0289-3.10.1007/s11886-012-0289-322821004Open DOISearch in Google Scholar

13. Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and metaanalysis. Circulation. 2011;123:1587-1593. doi: 10.1161/ CIRCULATIONAHA.110.986661.10.1161/CIRCULATIONAHA.110.986661308277321464054Open DOISearch in Google Scholar

14. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-76.Search in Google Scholar

15. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38-e360. doi: 10.1161/cir.0000000000000350.10.1161/cir.0000000000000350Open DOISearch in Google Scholar

16. Ghushchyan V, Nair KV, Page RL 2nd. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both. Vasc Health Risk Manag. 2015;11:25-34. doi: 10.2147/VHRM.S72331.10.2147/VHRM.S72331428404725565859Open DOISearch in Google Scholar

17. Lau DH, Alasady M, Brooks AG, Sanders P. New-onset atrial fibrillation and acute coronary syndrome. Expert Rev Cardiovasc Ther. 2010;8:941-948. doi: 10.1586/erc.10.61.10.1586/erc.10.6120602555Search in Google Scholar

18. Rubenstein JC, Cinquegrani MP, Wright J. Atrial Fibrillation in Acute Coronary Syndrome. Journal of Atrial Fibrillation. 2012;5:551. doi: 10.4022/jAF.551.10.4022/jAF.551Open DOISearch in Google Scholar

19. Anne W, Willems R, Roskams T, et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res. 2005;67:655-666. doi: 10.1016/j.cardiores.2005.04.016.10.1016/j.cardiores.2005.04.01615913581Open DOISearch in Google Scholar

20. Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm. 2009;6:454-460. doi: 10.1016/j. hrthm.2009.01.010.10.1016/j.hrthm.2009.01.010266213419324302Open DOISearch in Google Scholar

21. Spach MS, Josephson ME. Initiating reentry: the role of non-uniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 1994;5:182-209.Search in Google Scholar

22. Greiser M. Calcium signalling silencing in atrial fibrillation. J Physiol. 2017;595:4009-4017. doi: 10.1113/JP273045.10.1113/JP273045547136228332202Open DOISearch in Google Scholar

23. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50:e1- e88. doi: 10.1093/ejcts/ezw313.10.1093/ejcts/ezw313Open DOISearch in Google Scholar

24. Jalife J, Kaur K. Atrial Remodeling, Fibrosis and Atrial Fibrillation. Trends in cardiovascular medicine. 2015;25:475-484. doi: 10.1016/j.tcm.2014.12.015.10.1016/j.tcm.2014.12.015Open DOISearch in Google Scholar

25. Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250-3257. doi: 10.1093/ eurheartj/ehv513.10.1093/eurheartj/ehv513Open DOISearch in Google Scholar

26. Alasady M, Lau D, Brooks A, et al. Atrial ischemia rather than neurohormonal or hemodynamic changes associ¬ated with acute myocardial infarction results in substrate for atrial fibrillation. Heart, Lung and Circulation. 2010;19:S2. doi: 10.1016/j.hlc.2010.06.66810.1016/j.hlc.2010.06.668Open DOISearch in Google Scholar

27. Alasady M, Abhayaratna WP, Leong DP, et al. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm. 2011;8:955-960. doi: 10.1016/j. hrthm.2011.02.016.Search in Google Scholar

28. Ferreira JP, Santos M. Heart failure and atrial fibrillation: from basic science to clinical practice. Int J Mol Sci. 2015;16:3133-3147. doi: 10.3390/ijms16023133. 29. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-1847. doi: 10.1093/eurheartj/ehs104.10.3390/ijms16023133.29.etal.ESC2012:2012.(HFA)ESC.J.2012;33:1787-1847.doi:10.1093/eurheartj/ehs104Open DOISearch in Google Scholar

30. Kober L, Swedberg K, McMurray JJ, et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure of left ventricular dysfunction. Eur J Heart Fail. 2006;8:591-598. doi: 10.1016/j.ejheart.2005.11.007.10.1016/j.ejheart.2005.11.007Search in Google Scholar

31. Kochiadakis GE, Skalidis EI, Kalebubas MD, et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J. 2002;23:734-741. doi: 10.1053/euhj.2001.2894.10.1053/euhj.2001.2894Open DOISearch in Google Scholar

32. Ariyarajah V, Malinski M, Khadem A, et al. Relation of recurrence of atrial fibrillation after non-ST-elevation acute myocardial infarction to left atrial abnormality. Am J Cardiol. 2008;101:30-34. doi: 10.1016/j.amjcard.2007.07.044.10.1016/j.amjcard.2007.07.044Open DOISearch in Google Scholar

33. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: A vicious electromechanical cycle. Circulation. 2004;109:2839-2843. doi: 10.1161/01. CIR.0000132470.78896.A8.10.1161/01.CIR.0000132470.78896.A8Open DOISearch in Google Scholar

34. De Jong AM, Maass AH, Oberdorf-Maass SU, et al. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res. 2011;89:754-765. doi: 10.1093/cvr/cvq357.10.1093/cvr/cvq357Open DOISearch in Google Scholar

35. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263-2270. doi: 10.1016/j.jacc.2012.04.063.10.1016/j.jacc.2012.04.06323194937Open DOISearch in Google Scholar

36. Liuba L, Ahlomroth H, Jonasson L, et al. Source of inflammatory markers in patients with atrial fibrillation. Europace. 2008;10:848-53. doi: 10.1093/europace/eun111.10.1093/europace/eun11118523031Search in Google Scholar

37. Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010;7:438-444. doi: 10.1016/j.hrthm.2009.12.009.10.1016/j.hrthm.2009.12.009284377420153266Open DOISearch in Google Scholar

38. Pan M, Zhu JH, Jiang WP, et al. Inflammation: a possible pathogenic link to atrial fibrillation. Med Hypotheses. 2006;67:1305-1307. doi: 10.1016/j.mehy.2006.05.034.10.1016/j.mehy.2006.05.03416824699Open DOISearch in Google Scholar

39. Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol. 2007;100:753-757. doi: 10.1016/j.amjcard.2007.04.014.10.1016/j.amjcard.2007.04.01417719315Open DOISearch in Google Scholar

40. Hwang HJ, Ha JW, Joung B, et al. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol. doi: 10.1016/j. ijcard.2009.05.065.10.1016/j.ijcard.2009.05.06519570585Open DOISearch in Google Scholar

41. Ma CY, Xu ZY, Wang SP, et al. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome. Chinese Medical Journal. 2018;131:1444-1449. doi: 10.4103/0366-6999.233953.10.4103/0366-6999.233953600681129893361Open DOISearch in Google Scholar

42. Meuwissen M, van der Wal AC, Siebes M, et al. Role of plaque inflammation in acute and recurrent coronary syndromes. Netherlands Heart Journal. 2004;12:106-109.Search in Google Scholar

43. Centurion OA. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Cardiovasc Revasc Med. 2016;17:119-128. doi: 10.1016/j.carrev.2016.01.005.10.1016/j.carrev.2016.01.00526905055Open DOISearch in Google Scholar

44. Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. Journal of Geriatric Cardiology: JGC. 2015;12:305-312. doi: 10.11909/j.issn.1671-5411.2015.03.020.Search in Google Scholar

45. Frangogiannis NG. The inflammatory response in myocardialinjury, repair and remodeling. Nature Reviews Cardiology. 2014;11:255-265. doi: 10.1038/nrcardio.2014.28.10.1038/nrcardio.2014.28440714424663091Open DOISearch in Google Scholar

46. Sukhija R, Fahdi I, Garza L, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol. 2007;99:879-884. doi: 10.1016/j. amjcard.2006.11.032.10.1016/j.amjcard.2006.11.03217398176Open DOISearch in Google Scholar

47. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circulation Research. 2012;110:159-273. doi: 10.1161/CIRCRESAHA.111.243162.10.1161/CIRCRESAHA.111.243162369013522223212Open DOISearch in Google Scholar

48. Seropian IM, Toldo S, Van Tassell BW, Abbate A. Antiinflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63:1593-1603. doi: 10.1016/j.jacc.2014.01.014.10.1016/j.jacc.2014.01.01424530674Open DOISearch in Google Scholar

49. Westman PC1, Lipinski MJ1, Luger D, et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67:2050-2060. doi: 10.1016/j.jacc.2016.01.073.10.1016/j.jacc.2016.01.07327126533Open DOISearch in Google Scholar

50. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol. 2005;46:1496-1502. doi: 10.1016/j.jacc.2005.05.083.10.1016/j.jacc.2005.05.08316226174Open DOISearch in Google Scholar

51. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses. 2004;62:499-506. doi: 10.1016/j. mehy.2003.12.014.10.1016/j.mehy.2003.12.01415050096Open DOISearch in Google Scholar

52. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med. 2003;163:1323-1328. doi: 10.1001/ archinte.163.11.1323.10.1001/archinte.163.11.132312796068Open DOISearch in Google Scholar

53. Sheikh AS, Yahya S, Sheikh NS, et al. C-reactive protein as a predictor of adverse outcome in patients with acute coronary syndrome. Heart Views. 2012;13:7-12. doi: 10.4103/1995-705X.96660.10.4103/1995-705X.96660338519722754634Open DOISearch in Google Scholar

54. Valgimigli M, Ceconi C, Malagutti P, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation. 2005;111:863-870. doi: 10.1161/01.CIR.0000155614.35441.69.10.1161/01.CIR.0000155614.35441.6915699251Search in Google Scholar

55. Andrie RP, Becher UM, Frommold R, et al. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care. 2012;16:R152.10.1186/cc11467358074122889197Search in Google Scholar

56. Dayawansa NH, Gao XM, White DA, et al. Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings. Clin Sci. 2014;127:149-161. doi: 10.1042/CS20130828.10.1042/CS2013082824697297Open DOISearch in Google Scholar

57. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26:2083-2092. doi: 10.1093/eurheartj/ehi350.10.1093/eurheartj/ehi35015975993Open DOISearch in Google Scholar

58. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136-149. doi: 10.1093/eurheartj/ehi645.10.1093/eurheartj/ehi64516278230Open DOISearch in Google Scholar

59. Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:1064-1070. doi: 10.1111/j.1540-8167.2010.01774.x.10.1111/j.1540-8167.2010.01774.x20455973Open DOISearch in Google Scholar

60. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-1184.10.1161/01.CIR.96.4.11809286947Search in Google Scholar

61. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010. doi: 10.1161/01.CIR.0000103131.70301.4F.10.1161/01.CIR.0000103131.70301.4Open DOISearch in Google Scholar

62. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.10176011739301Search in Google Scholar

63. Kallergis EM, Manios EG, Kanoupakis EM, et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart. 2008;94:200-204. doi: 10.1136/hrt.2006.108688.10.1136/hrt.2006.10868817575330Open DOISearch in Google Scholar

64. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J. 2008;155:303-309. doi: 10.1016/j.ahj.2007.09.006.10.1016/j.ahj.2007.09.006224736618215601Open DOISearch in Google Scholar

65. Floria M, Barboi O, Rezus C, et al. Atrial Fibrillation and Gastro-Oesophageal Reflux Disease - Controversies and Challenges. Curr Pharm. 2015;21:3829-3834.10.2174/138161282166615031910000325786404Search in Google Scholar

66. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50:2021-2028. doi: 10.1016/j.jacc.2007.06.054.10.1016/j.jacc.2007.06.05418021867Open DOISearch in Google Scholar

67. Pellegrino PL, Brunetti ND, Gennaro LD, Ziccardi L, Grimaldi M, Biase MD. Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset. Intern Emerg Med. 2011;8:123-128. doi: 10.1007/s11739-011- 0557-z.Search in Google Scholar

68. Marcus GM, Smith L, Ordovas K, et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm. 2010;7:149-154. doi: 10.1016/j. hrthm.2009.10.004.10.1016/j.hrthm.2009.10.004Open DOISearch in Google Scholar

69. Conway DS, Buggins P, Hughes E, Lip GY. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J. 2004;148:462-466. doi: 10.1016/j.ahj.2004.01.026.10.1016/j.ahj.2004.01.026Open DOISearch in Google Scholar

70. Conway DS, Buggins P, Hughes E, Lip GY. Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol. 2004;93:1368-1373. doi: 10.1016/j. amjcard.2004.02.032.10.1016/j.amjcard.2004.02.032Open DOISearch in Google Scholar

71. Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol. 2007;100:753-757. doi: 10.1016/j.amjcard.2007.04.014.10.1016/j.amjcard.2007.04.014Open DOISearch in Google Scholar

72. Hwang HJ, Ha JW, Joung B, et al. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol. 2011;146:28-31. doi: 10.1016/j.ijcard.2009.05.065.10.1016/j.ijcard.2009.05.065Open DOISearch in Google Scholar

73. Ren Y, Zeng RX, Li JJ, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction: A systematic review and meta-analysis. Int J Cardiol. 2015;190:268-70. doi: 10.1016/j.ijcard.2015.04.152.10.1016/j.ijcard.2015.04.152Open DOISearch in Google Scholar

74. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039-1045.10.1016/S0735-1097(97)00254-4Search in Google Scholar

75. Roy D, Brugada P, Wellens HJ. Atrial tachycardia facilitating initiation of ventricular tachycardia. Pacing Clin Electrophysiol. 1983;6:47-52.10.1111/j.1540-8159.1983.tb06581.x6188124Search in Google Scholar

76. Gronefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol. 2000;11:1208-14.10.1046/j.1540-8167.2000.01208.x11083241Search in Google Scholar

77. Vukmirović M, Bošković A, Tomašević Vukmirović I, et al. Predictions and Outcomes of Atrial Fibrillation in the Patients with Acute Myocardial Infarction. Open Medicine. 2017;12:115-124. doi: 10.1515/med-2017-0018.10.1515/med-2017-0018544440428730170Open DOISearch in Google Scholar

78. Munger TM, Dong YX, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851-860. doi: 10.1016/j.jacc.2012.03.042.10.1016/j.jacc.2012.03.042Open DOISearch in Google Scholar

79. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation, evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol. 2001;56:375-380.10.2143/AC.56.6.2005701Search in Google Scholar

80. Parashar S, et al. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol. 2013;112:1390-1395.10.1016/j.amjcard.2013.07.006Search in Google Scholar

81. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:406-413.10.1016/S0735-1097(97)00194-0Search in Google Scholar

82. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92:1150-1154.10.1016/j.amjcard.2003.07.02114609587Search in Google Scholar

83. Park MJ, Jung JI, Oh YS, Youn HJ. Assessment of the structural remodeling of the left atrium by 64-multislice cardiac CT: comparative studies in controls and patients with atrial fibrillation. Int J Cardiol. 2012;159:181-186. doi: 10.1016/j. ijcard.2011.02.053.10.1016/j.ijcard.2011.02.05321420185Open DOISearch in Google Scholar

84. Jabre P, Jouven X, Adnet F, et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation. 2011;123:2094-2100. doi: 10.1161/ CIRCULATIONAHA.110.990192.10.1161/CIRCULATIONAHA.110.990192314291421536994Open DOISearch in Google Scholar

85. Podolecki T, Lenarczyk R, Kowalczyk J, et al. Effect of type of atrial fibrillation on prognosis in acute myocardial infarction treated invasively. Am J Cardiol. 2012;109:1689-1693. doi: 10.1016/j.amjcard.2012.02.009.10.1016/j.amjcard.2012.02.00922440129Open DOISearch in Google Scholar

86. Rene AG, Généreux P, Ezekowitz M, et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113:236-242.10.1016/j.amjcard.2013.09.01624176066Search in Google Scholar

87. Guenancia C, Stamboul K, Garnier F, et al. Obesity and newonset atrial fibrillation in acute myocardial infarction: a gender specific risk factor. Int J Cardiol. 2014;176:1039-1041. doi: 10.1016/j.ijcard.2014.07.291.10.1016/j.ijcard.2014.07.29125156840Open DOISearch in Google Scholar

88. Siu CW, Jim MH, Ho HH, Miu R, Lee SW, Lau CP. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest. 2007;132:44-49. doi: 10.1378/chest.06-2733.10.1378/chest.06-273317400657Open DOISearch in Google Scholar

89. Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent- Martin M. Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss. 2005;98:608-614.Search in Google Scholar

90. Kosmidou I, Chen S, Kappetein AP, et al. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial. J Am Coll Cardiol. 2018;71:739-748. doi: 10.1016/j. jacc.2017.12.012.10.1016/j.jacc.2017.12.01229447735Open DOISearch in Google Scholar

91. Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51:793-801. doi: 10.1016/j. jacc.2007.10.043.10.1016/j.jacc.2007.10.04318294562Open DOISearch in Google Scholar

92. Chelazzi C, Villa G, De Gaudio AR. Postoperative Atrial Fibrillation. ISRN Cardiology. 2011;2011:203179. doi:10.5402/2011/203179.10.5402/2011/203179326250822347631Search in Google Scholar

93. Alawami M, Chatfield A, Ghashi R, Walker L. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. Journal of the Saudi Heart Association. 2018;30:40-46. doi: 10.1016/j.jsha.2017.03.008.10.1016/j.jsha.2017.03.008574403129296063Open DOISearch in Google Scholar

94. Alqahtani AAR. Atrial Fibrillation Post Cardiac Surgery Trends Toward Management. Heart Views : The Official Journal of the Gulf Heart Association. 2010;11:57-63. doi: 10.4103/1995- 705X.73212.10.4103/1995-705X.73212300091321187998Open DOISearch in Google Scholar